The Original Investigation titled “Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US,” published online August 20, 2025, and in the October 2025 issue was corrected to fix the analytic sample size reported in the results. The sample size was originally reported as 133.6 million; the correct value is 113.6 million. This article was corrected online.
Reference
- 1.Khan SS, Huang X, Ndumele CE, et al. Statin eligibility according to atherosclerotic cardiovascular disease risk in the US. JAMA Cardiol. 2025;10(10):1071-1073. doi: 10.1001/jamacardio.2025.2725 [DOI] [PMC free article] [PubMed] [Google Scholar]
